A multibillion-dollar market may await ScarX, a Toronto biomedical start-up, but first it had to figure out how to finance the development of its unique cream that reduces scarring after surgery…
Looking to China for start-up funding
A Toronto biomedical firm finds development funds for its anti-scarring medication in exchange for rights to Chinese market
- By: Sean Fine
- From: ROB.com
- Date: Tuesday September 25th, 2012






Twitter





Be the first to comment on this article.